ACSL4 and neoplasm: Increased expression of ACSL4 in the TNBC cell line MDA-MB-157 enhances the sensitivity of cancer tissue to the ferroptosis inducer RSL3, while deletion of ACSL4 prevents cancer cells from undergoing RSL3-induced ferroptosis and leads to increased tumor volume in vivo (117).